Teva Divests Takeda JV, Pivots To Innovative Drugs In Japan

Takeda Expects $365m Payment

 
• By Lisa Takagi
  
Teva decided to divest Takeda JV (Shutterstock)

More from Strategy

More from Generics Bulletin